Efficacy and Safety of Rimegepant for the Acute Treatment of Migraine: Evidence From Randomized Controlled Trials
Conclusions75 mg rimegepant had good efficacy and safety for acute treatment of migraine. Further studies are needed to compare the efficacy of rimegepant with traditional drugs for acute management of migraine.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Brain | Clinical Trials | Databases & Libraries | Drugs & Pharmacology | Genetics | Headache | Migraine | Neurology | Pain | Pain Management | Statistics | Study